| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.01. | KMTS, Biobeat Partner to Expand Diagnostic Insight in Cardiac Recovery | 4 | Zacks | ||
| 13.01. | Kestra Medical partners with Biobeat to add blood pressure monitoring | 2 | Investing.com | ||
| 13.01. | Kestra Medical kooperiert mit Biobeat und integriert Blutdruckmessung in tragbaren Defibrillator | 1 | Investing.com Deutsch | ||
| 13.01. | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Announces Strategic Collaboration with Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery | 315 | GlobeNewswire (Europe) | KIRKLAND, Wash., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced a strategic... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 12.12.25 | Kestra Medical Technologies stock price target raised by Stifel to $30 | 2 | Investing.com | ||
| 12.12.25 | Stifel hebt Kursziel für Kestra Medical Technologies auf 30 $ an | 5 | Investing.com Deutsch | ||
| 12.12.25 | Kestra Medical Technologies stock price target raised to $30 from $27 at Piper Sandler | 5 | Investing.com | ||
| 11.12.25 | Earnings Call Transkript: Kestra Medical Technologies Q2 2025 zeigt starkes Umsatzwachstum | 2 | Investing.com Deutsch | ||
| 11.12.25 | Kestra Medical Technologies, Ltd. GAAP EPS of -$0.64 misses by $0.05, revenue of $22.56M beats by $1.6M | 1 | Seeking Alpha | ||
| 11.12.25 | KESTRA MEDICAL TECHNOLOGIES, LTD. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 11.12.25 | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results | 174 | GlobeNewswire (Europe) | KIRKLAND, Wash., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for... ► Artikel lesen | |
| 11.12.25 | KESTRA MEDICAL TECHNOLOGIES, LTD. - 8-K, Current Report | - | SEC Filings | ||
| 03.12.25 | Kestra Medical Technologies, Ltd. to Report Second Quarter Fiscal 2026 Financial Results | 1 | GlobeNewswire (USA) | ||
| 03.12.25 | Kestra Medical Technologies prices $138M offering | 2 | MassDevice | ||
| 03.12.25 | Kestra Medical prices upsized $138M offering | 4 | Seeking Alpha | ||
| 03.12.25 | Kestra Medical Technologies prices upsized public offering at $23 per share | 5 | Investing.com | ||
| 03.12.25 | Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Primary Public Offering of Common Shares | 2 | GlobeNewswire (USA) | ||
| 01.12.25 | Kestra Medical Technologies sees Q2 revenue between $22.2M and $22.6M | 3 | Seeking Alpha | ||
| 01.12.25 | Kestra Medical Technologies announces public offering of common shares | 2 | Seeking Alpha | ||
| 01.12.25 | Kestra Medical announces public offering of 5.5 million shares | 2 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 15,440 | +1,65 % | Picks and shovels play intact, chg.: FY25 prelims confirm Eckert & Ziegler's earnings momentum, with China and isotope ... | Novo Nordisk's c.17% share price drop underscores how quickly sentiment can turn in single product healthcare stories, especially when patent cycle concerns resurface. In contrast, EUZ is "picks and... ► Artikel lesen | |
| HIMS & HERS HEALTH | 19,500 | +0,15 % | Hims & Hers-Aktie -10%: Warum profitiert sie nicht? | Die Hims & Hers-Aktie schoss am gestrigen Donnerstag kurzfristig um über +10% in die Höhe, beendete den Handelstag dann aber doch mit einem Minus von fast -4%. Am Freitagmorgen bricht der Kurs der Gesundheitsplattform... ► Artikel lesen | |
| RADNET | 59,00 | 0,00 % | RadNet, Inc.: RadNet Enters Indiana with Acquisition of Northwest Radiology | LOS ANGELES, Feb. 03, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a global developer... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,740 | +4,89 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,680 | +3,44 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| INFUSYSTEM | 7,000 | +6,87 % | InfuSystem Holdings, Inc - 8-K, Current Report | ||
| IRADIMED | 79,00 | -3,07 % | Dividendenbekanntmachungen (17.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMERIGO RESOURCES LTD CA03074G1090 0,05 CAD 0,0309 EUR ARES MANAGEMENT CORPORATION US03990B1017 1,12 USD 0,9533 EUR BANK OF COMMUNICATIONS... ► Artikel lesen | |
| BETA BIONICS | 13,080 | -1,28 % | Beta Bionics receives FDA warning letter | ||
| SIEMENS HEALTHINEERS | 41,400 | -2,82 % | Märkte am Morgen: Gold, Silber, Bitcoin, Amgen, Alphabet, AMD, SAP, Siemens Healthineers, BASF | Das Umfeld an den Aktienmärkten ist aktuell alles andere als einfach. Das hat sich gestern mal wieder deutlich gezeigt. Der DAX geriet nach guten Start unter Druck und schloss 0,72 Prozent tiefer bei... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,640 | +0,40 % | DAX-Check LIVE: Fresenius Medical Care, Nordex, Puma, Sartorius Vz., Schaeffler, Siltronic im Fokus | Ein kurzzeitiger Ausverkauf bei Gold und Silber hat den DAX zum Wochenstart zunächst belastet. Die Unsicherheit beruhigte sich jedoch im Tagesverlauf, auch unterstützt durch eine Erholung an den US-Märkten.... ► Artikel lesen | |
| FRESENIUS | 49,760 | +1,06 % | Fresenius: 2026 setzt sich das Wachstum fort | Am 25. Februar wird Fresenius Zahlen zum vierten Quartal publizieren. Die Analysten der DZ Bank rechnen mit einer soliden Entwicklung. Wachstumsinvestitionen bei Kabi dürften sich bei den Margen bemerkbar... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 27,520 | +0,66 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 49 auf 32 Euro gesenkt und die Aktien von "Overweight" auf "Equal Weight" abgestuft. Nur... ► Artikel lesen | |
| HEARTFLOW | 27,690 | +6,54 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| GENEDX | 84,35 | +0,32 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,990 | +2,23 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen |